Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate
- 1 April 2003
- Vol. 61 (4) , 730-735
- https://doi.org/10.1016/s0090-4295(02)02425-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trialsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1999
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Prognostic factors for clinically localized prostate carcinomaCancer, 1997
- A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaCancer, 1997
- Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapyRadiotherapy and Oncology, 1992
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958